Alan R. Katz to Prostate-Specific Antigen
This is a "connection" page, showing publications Alan R. Katz has written about Prostate-Specific Antigen.
Connection Strength
0.053
-
Ma TM, Roy S, Wu X, Mantz C, Fuller D, Miszczyk L, Napieralska A, Namysl-Kaletka A, Bagshaw HP, Buyyounouski MK, Glicksman R, Loblaw DA, Katz A, Upadhyaya SK, Nickols N, Steinberg ML, Philipson R, Aghdam N, Suy S, Pepin A, Collins SP, Boutros P, Rettig MB, Calais J, Wang M, Zaorsky N, Kishan AU. Refining the definition of biochemical failure in the era of stereotactic body radiation therapy for prostate cancer: The Phoenix definition and beyond. Radiother Oncol. 2022 01; 166:1-7.
Score: 0.042
-
Tudiver F, Guibert R, Haggerty J, Ciampi A, Medved W, Brown JB, Herbert C, Katz A, Ritvo P, Grant B, Goel V, Smith P, O'Beirne M, Williams JI, Moliner P. What influences family physicians' cancer screening decisions when practice guidelines are unclear or conflicting? J Fam Pract. 2002 Sep; 51(9):760.
Score: 0.011